Skip to content

NEW peer reviewed evidence on the benefits of using CytoSorb Therapy in COVID-19 patients

presented by Dr. Volker Humbert

  • Continuous renal replacement therapy with the addition of CytoSorb cartridge in 50 critically ill patients with COVID-19 plus acute kidney injury: a case-series
  • Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia
Play Video

Share

|

NEW peer reviewed evidence on the benefits of using CytoSorb Therapy in COVID-19 patients

Play Video

Share

|

presented by Dr. Volker Humbert

  • Continuous renal replacement therapy with the addition of CytoSorb cartridge in 50 critically ill patients with COVID-19 plus acute kidney injury: a case-series
  • Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia